OpGen, Inc.
Index- P/E- EPS (ttm)-1.19 Insider Own0.30% Shs Outstand40.58M Perf Week20.36%
Market Cap18.41M Forward P/E- EPS next Y-0.49 Insider Trans45.29% Shs Float38.87M Perf Month-36.85%
Income-42.00M PEG- EPS next Q-0.15 Inst Own11.30% Short Float3.04% Perf Quarter-59.48%
Sales4.30M P/S4.28 EPS this Y31.00% Inst Trans2.53% Short Ratio3.07 Perf Half Y-76.82%
Book/sh1.02 P/B0.37 EPS next Y32.30% ROA-50.60% Target Price3.00 Perf Year-81.25%
Cash/sh0.75 P/C0.51 EPS next 5Y- ROE-87.60% 52W Range0.31 - 3.72 Perf YTD-61.75%
Dividend- P/FCF- EPS past 5Y70.90% ROI-36.60% 52W High-89.72% Beta-0.39
Dividend %- Quick Ratio1.90 Sales past 5Y1.40% Gross Margin33.90% 52W Low23.39% ATR0.06
Employees99 Current Ratio2.00 Sales Q/Q0.00% Oper. Margin- RSI (14)34.27 Volatility12.13% 13.85%
OptionableNo Debt/Eq0.53 EPS Q/Q-2.50% Profit Margin- Rel Volume1.30 Prev Close0.37
ShortableYes LT Debt/Eq0.17 EarningsMay 12 AMC Payout- Avg Volume384.62K Price0.38
Recom2.00 SMA20-19.17% SMA50-41.29% SMA200-74.60% Volume495,685 Change3.41%
Mar-01-19Initiated Alliance Global Partners Buy $2.30
Feb-07-18Reiterated H.C. Wainwright Buy $1 → $9
Jun-29-16Initiated Rodman & Renshaw Buy $2.50
May-12-22 05:35PM  
Apr-28-22 07:30AM  
Apr-25-22 07:30AM  
Apr-20-22 07:30AM  
Apr-06-22 07:30AM  
Apr-05-22 07:30AM  
Mar-29-22 07:25PM  
Mar-24-22 07:05PM  
Mar-15-22 07:30AM  
Feb-28-22 07:55PM  
Feb-10-22 04:30PM  
Jan-18-22 07:30AM  
Jan-10-22 07:30AM  
Dec-14-21 07:30AM  
Dec-08-21 04:30PM  
Nov-30-21 08:45AM  
Nov-11-21 04:05PM  
Nov-04-21 03:01PM  
Oct-28-21 07:30AM  
Oct-21-21 07:30AM  
Oct-18-21 04:30PM  
Oct-14-21 08:00AM  
Oct-05-21 05:17AM  
Oct-04-21 02:59PM  
Sep-30-21 07:30AM  
Sep-16-21 09:03AM  
Sep-15-21 07:30AM  
Aug-12-21 07:55PM  
Aug-04-21 04:30PM  
Aug-03-21 07:30AM  
Jul-07-21 04:30PM  
Jun-30-21 07:30AM  
Jun-28-21 07:30AM  
Jun-15-21 02:14PM  
Jun-09-21 04:30PM  
Jun-07-21 10:36AM  
May-13-21 12:11PM  
Apr-29-21 12:34PM  
Apr-19-21 07:30AM  
Apr-12-21 07:30AM  
Mar-26-21 03:28AM  
Mar-25-21 05:25PM  
Mar-24-21 10:04AM  
Mar-18-21 12:30PM  
Mar-11-21 07:30AM  
Mar-09-21 08:03AM  
Mar-08-21 07:30AM  
Mar-01-21 07:30AM  
Feb-22-21 09:47AM  
Feb-16-21 07:30AM  
Feb-09-21 08:30AM  
Jan-13-21 11:02AM  
Jan-11-21 10:11AM  
Jan-05-21 07:30AM  
Dec-17-20 08:00AM  
Dec-09-20 07:30AM  
Dec-01-20 07:30AM  
Nov-24-20 08:00AM  
Nov-12-20 07:30AM  
Nov-11-20 04:05PM  
Oct-29-20 07:30AM  
Oct-28-20 07:30AM  
Oct-26-20 09:51AM  
Oct-15-20 07:30AM  
Oct-14-20 07:53AM  
Oct-13-20 05:00PM  
Oct-12-20 10:19AM  
Oct-05-20 08:19AM  
Sep-30-20 07:30AM  
Sep-28-20 07:30AM  
Sep-18-20 04:30PM  
Sep-16-20 07:30AM  
Sep-08-20 07:30AM  
Sep-02-20 07:30AM  
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen; and QuickFISH and PNA FISH diagnostic test products for the identification of various infectious pathogens, as well as SARS CoV-2 test kits. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics, which combines clinical lab test results with patient and hospital information to provide analytics and insights to enable manage MDROs in the hospital and patient care environment; Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers; and ARES Technology Platform, including ARESdb, which provides next generation sequencing based and artificial intelligence powered, cloud-based bioinformatics solutions to generate AMR profiles, as well as predict antimicrobial susceptibility test results. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is based in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bacher JohannesChief Operating OfficerMar 03Option Exercise0.0021,250081,250Mar 04 11:03 AM
Schacht OliverChief Executive OfficerMar 03Option Exercise0.0038,750068,750Mar 04 11:01 AM
Bacher JohannesChief Operating OfficerJan 26Buy0.8525,00021,25060,000Jan 27 06:19 AM
Bacher JohannesChief Operating OfficerNov 19Buy1.5310,00015,34735,000Nov 19 02:46 PM
Schacht OliverChief Executive OfficerNov 18Buy1.5010,00014,96030,000Nov 19 08:48 AM
Schacht OliverChief Executive OfficerSep 15Buy3.085,00015,40020,000Sep 15 04:21 PM
Bacher JohannesChief Operating OfficerSep 15Buy3.075,00015,35025,000Sep 16 06:03 AM
Schacht OliverChief Executive OfficerJun 10Buy2.245,00011,1855,000Jun 14 04:29 PM
Schacht OliverChief Executive OfficerJun 10Buy2.2315,00033,51615,000Jun 14 04:29 PM
Bacher JohannesChief Operating OfficerJun 10Buy2.2720,00045,49420,000Jun 14 04:21 PM